Reported 2026-07-25Lot KLOW-072026-199.54% purity · GHK-Cu - 56.58 mg, KPV - 10.25 mg, Thymosin Beta-4 - 12.16 mg, BPC-157 - 11.38 mg
Open COA
Lyophilized Peptides
GHK-CU/BPC-157/TB-500/KPV KLOW Blend
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogKLOW-PW-50MG-10MG-10MG-10MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$140.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
8293 in stock
Current product record, labeling and lot documentation control intended use and handling.
GHK-CU/BPC-157/TB-500/KPV KLOW Blend$140.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
9 approved certificates are attached to this product record.
Reported 2026-03-24Lot KLOW-032026-199.61% purity · GHK-Cu - 50.25 mg, KPV - 8.74 mg, BPC-157 - 10.46 mg, Thymosin Beta-4 - 8.49 mg
Open COA
Reported 2026-03-11Lot Klow-032026-499.76% purity · GHK-Cu – 53.33 mg KPV – 7.99 mg TB-500 – 9.61 mg BPC-157 – 10.57 mg
Open COA
Reported 2025-10-14Lot KLOW8010082025-0299.68% purity · GHK-Cu- 49.26 mg, KPV- 9.74 mg, BPC-157- 9.83 mg, Thymosin Beta-4- 10.25 mg
Open COA
Reported 2025-10-14Lot EPIT10102025-J99.504% purity · 10.05 mg
Open COA
Reported 2025-09-17Lot KLOW091220205-J99.91% purity · GKH-Cu- 50.76 mg, KPV- 9.50 mg, BPC-157- 9.72 mg, Thymosin Beta-4- 12.35 mg
Open COA
Reported 2025-09-17Lot KLOW091920205-J99.91% purity · GKH-Cu- 50.76 mg, KPV- 9.50 mg, BPC-157- 9.72 mg, Thymosin Beta-4- 12.35 mg
Open COA
Reported 2025-07-10Lot KLOWBLEND072025-P99.19% purity · CHK-Cu: 46.35 mg, KPV: 9.97 mg, BPC-157: 9.12 mg, Thymosin Beta-4: 9.27 mg
Open COA
Reported 2025-06-19Lot KLOWBLEND0620205-N99.88% purity · GHK-Cu: 47.29 mg, KPV: 9.47 mg, BPC-157: 10.14 mg, Thymosin Beta-4: 10.02 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- KLOW-PW-50MG-10MG-10MG-10MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference KLOW-PW-50MG-10MG-10MG-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model